What Is Iron Deficiency and Ferritin

Iron deficiency is the most common nutritional deficiency globally, occurring when the body's iron stores are insufficient to support normal physiological function. Ferritin is the intracellular protein that stores iron and releases it in a controlled fashion; a serum ferritin test is the most widely used indicator of total body iron status. When ferritin is low, iron-dependent processes including oxygen transport, energy metabolism, and neurotransmitter synthesis are compromised.

Iron sits at the center of oxygen delivery and cellular energy production. Every molecule of hemoglobin requires four iron atoms to bind oxygen, and mitochondrial electron transport chain complexes depend on iron-sulfur clusters to generate ATP. When stores are depleted, the consequences extend far beyond the classic image of pale skin and fatigue: cognitive performance declines, thyroid hormone conversion slows, immune function weakens, and exercise capacity drops. These effects can be subtle and easily attributed to aging, stress, or poor sleep, which means iron deficiency frequently goes unrecognized for years.

For longevity, iron status represents a fundamental input that influences multiple aging-relevant systems. Chronic low-grade iron deficiency accelerates wear on the cardiovascular system by forcing the heart to compensate for reduced oxygen-carrying capacity. It disrupts hormonal cascades because iron is a cofactor for enzymes involved in steroid and thyroid hormone metabolism. And it impairs the body's regenerative capacity, since stem cell proliferation and tissue repair are iron-dependent processes. Identifying and correcting deficiency is one of the higher-yield interventions available, particularly for premenopausal women, yet it remains underdiagnosed partly because conventional reference ranges for ferritin set the "normal" floor too low.

Iron absorbed from food or supplements enters the bloodstream bound to a transport protein called transferrin. Cells throughout the body take up transferrin-bound iron via transferrin receptors, and once inside, iron is either used immediately (incorporated into hemoglobin, myoglobin, or enzymatic complexes) or stored within ferritin molecules. Each ferritin shell can hold up to 4,500 iron atoms, releasing them as the body requires. Serum ferritin reflects what has leaked from cells into the blood and correlates with total body iron stores, making it the standard clinical proxy.

Iron homeostasis is governed primarily by hepcidin, a peptide hormone produced by the liver. When iron stores are sufficient, hepcidin levels rise, blocking the iron exporter ferroportin on intestinal cells and macrophages and thereby reducing absorption and recycling. When stores fall, hepcidin drops, opening the gates for more iron to enter circulation. Inflammation complicates this picture because inflammatory cytokines, particularly interleukin-6, stimulate hepcidin production independently of iron status. This means that someone with chronic low-grade inflammation can have functionally restricted iron availability even when dietary intake is adequate, a pattern sometimes called functional iron deficiency or anemia of chronic disease.

At the mitochondrial level, iron is essential for several steps in the electron transport chain and for the synthesis of heme, which is required not only by hemoglobin but also by cytochrome enzymes involved in detoxification and energy production. Iron-sulfur cluster assembly is another critical pathway: defects in this process impair ATP synthesis and increase mitochondrial reactive oxygen species. The body has no regulated excretion mechanism for iron (losses occur mainly through shed intestinal cells, skin, and bleeding), which is why both deficiency and excess are clinically significant.

Iron status and hormonal health are deeply intertwined in women. Menstruation is the most obvious link: each cycle results in the loss of approximately 1 mg of iron per day of bleeding, and women with heavy periods (menorrhagia) can lose several times that amount. Conditions that alter menstrual flow, including uterine fibroids, endometriosis, and hormonal imbalances involving estrogen dominance, amplify these losses. During perimenopause, unpredictable and often heavier cycles can rapidly deplete stores that were already marginal.

Iron also participates directly in hormone synthesis and metabolism. Thyroid peroxidase, the enzyme that attaches iodine to thyroglobulin to form thyroid hormones, requires iron as a cofactor. Women with low ferritin frequently present with symptoms that overlap with hypothyroidism (fatigue, cold hands, weight gain, brain fog), and in some cases, correcting iron status improves thyroid function without any change in thyroid medication. Progesterone and estrogen metabolism involve cytochrome P450 enzymes in the liver, which are heme-dependent. Depleted iron may therefore subtly alter the balance of circulating sex hormones, though this area remains less well characterized in clinical research.

During pregnancy, iron requirements roughly triple to support fetal development, placental growth, and expanded maternal blood volume. Postpartum, blood loss during delivery can further deplete stores, contributing to postpartum fatigue and mood disturbance that is sometimes misattributed entirely to sleep deprivation or hormonal shifts.

The symptoms of iron deficiency are notoriously nonspecific, which is why it is so often missed. Fatigue is the hallmark complaint, but it presents across a wide spectrum: some women describe a persistent heaviness or inability to recover from exertion, while others notice that their baseline energy has gradually eroded without an identifiable cause. Exercise intolerance is common; heart rate rises disproportionately during moderate activity, and recovery takes longer than expected.

Beyond fatigue, iron deficiency produces a constellation of signs that can point a clinician toward the diagnosis. Hair thinning, particularly diffuse shedding or loss at the temples, is one of the more recognizable presentations. Restless legs syndrome, especially symptoms that worsen at night, has a well-established association with low ferritin. Brittle or spoon-shaped nails (koilonychia), pallor of the inner lower eyelid and nail beds, shortness of breath on exertion, and difficulty concentrating all belong to the clinical picture. Pica, the craving for non-food substances like ice, dirt, or starch, is a specific but underreported symptom. Some women experience increased anxiety or depressive symptoms because iron is a cofactor for the enzymes that synthesize dopamine and serotonin. Cold intolerance is another signal, reflecting impaired thyroid function and reduced oxygen delivery to peripheral tissues.

Oral iron supplementation is the first-line approach for most cases of iron deficiency. Iron bisglycinate (chelated iron) is preferred by many practitioners because it causes fewer gastrointestinal side effects than ferrous sulfate and is reasonably well absorbed. Taking iron with a source of vitamin C (ascorbic acid) enhances absorption by reducing ferric iron to its more absorbable ferrous form. Dosing every other day rather than daily has been shown in studies to improve fractional absorption by allowing time for intestinal hepcidin levels to reset, and this approach may also reduce side effects.

Dietary strategies focus on increasing heme iron intake through red meat, liver, mussels, and oysters, which are the most bioavailable food sources. Non-heme iron from plant foods (spinach, lentils, fortified cereals) is absorbed at a much lower rate and is more susceptible to inhibition by phytates, polyphenols, and calcium. Pairing non-heme sources with vitamin C and avoiding coffee or tea within an hour of meals can partially offset this disadvantage. For vegetarians and vegans, a combination of strategic food pairing and supplementation is typically necessary to maintain adequate stores.

Intravenous iron infusion is appropriate when oral supplementation is poorly tolerated, when malabsorption is present (as in celiac disease or inflammatory bowel disease), or when rapid repletion is needed (severe deficiency, upcoming surgery, or late pregnancy). Modern IV iron formulations such as ferric carboxymaltose and iron sucrose have favorable safety profiles, though anaphylactoid reactions remain a rare possibility. Any repletion strategy should include follow-up testing at 8 to 12 week intervals to track ferritin response and adjust the plan accordingly.

Iron deficiency is among the most extensively studied nutritional deficiencies in medicine. Large epidemiological studies and meta-analyses consistently confirm that premenopausal women are the highest-risk demographic, with prevalence estimates ranging from 10% to over 30% depending on the population studied and the ferritin cutoff used. Multiple randomized controlled trials have demonstrated that iron supplementation improves fatigue, cognitive function, and exercise performance in iron-deficient non-anemic individuals, though the magnitude of benefit varies. The relationship between iron status and thyroid function has been supported by observational studies showing that low ferritin correlates with impaired T4-to-T3 conversion and higher TSH levels.

Key knowledge gaps remain. The optimal ferritin target is debated: while most researchers agree that levels below 15 ng/mL indicate depleted stores, the threshold at which symptoms emerge varies between individuals, and no large trial has definitively established an ideal range. Intravenous iron formulations have been studied in populations with malabsorption or intolerance to oral iron, showing faster repletion with generally acceptable safety profiles, but long-term data on repeated infusions are limited. The interaction between inflammation and iron homeostasis (via hepcidin) complicates interpretation of ferritin in people with chronic disease, autoimmune conditions, or obesity, and standardized approaches to diagnosing deficiency in these populations are still evolving.

Iron is unusual among nutrients because the body has no active excretion pathway; excess accumulates and acts as a pro-oxidant, catalyzing free radical formation through Fenton chemistry. Over-supplementation can cause gastrointestinal distress, constipation, and nausea in the short term, and liver damage or increased cardiovascular risk with chronic excess. People with hereditary hemochromatosis or other iron-loading conditions can be seriously harmed by unnecessary supplementation. Ferritin can be falsely elevated by inflammation, liver disease, or metabolic syndrome, leading to missed diagnoses of concurrent deficiency. For these reasons, supplementation should always be guided by laboratory testing rather than symptoms alone, and levels should be monitored during repletion to avoid overshooting.